Literature DB >> 3697988

Antigens expressed on NIH 3T3 cells following transformation with DNA from human pancreatic tumor.

M A Hollingsworth, L M Rebellato, J W Moore, O J Finn, R S Metzgar.   

Abstract

This report documents that the pancreatic adenocarcinoma cell line, HPAF, contains oncogene activity detected by transformation of NIH 3T3 cells through transfection with HPAF DNA. The HPAF transfected NIH 3T3 cells do not contain oncogenes homologous with c-H-ras, c-K-ras, c-N-ras, v-fms, c-myb, c-sis, v-fgr, c-mos, c-myc, c-fos, v-fes, v-src, v-erb A, v-erb B, c-N-myc, v-raf, or v-abl, other than the endogenous mouse genes. The transfectants do express proteins detected by two-dimensional sodium dodecyl sulfate-polyacrylamide gel electrophoresis which were not found in nontransfected NIH 3T3 cells. Monoclonal antibodies raised against the transfectants recognize proteins not found in untransfected NIH 3T3 cells that are antigenically identical to proteins found in the HPAF cells. These antigens are also detected on six other human pancreatic adenocarcinoma cell lines but show a much more restricted distribution on lymphoblastoid, melanoma, prostatic carcinoma, and normal skin fibroblast cell lines.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3697988

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  3 in total

1.  Preparation of Proper Immunogen by Cloning and Stable Expression of cDNA coding for Human Hematopoietic Stem Cell Marker CD34 in NIH-3T3 Mouse Fibroblast Cell Line.

Authors:  Farzaneh Shafaghat; Hajar Abbasi-Kenarsari; Jafar Majidi; Ali Akbar Movassaghpour; Dariush Shanehbandi; Tohid Kazemi
Journal:  Adv Pharm Bull       Date:  2015-03-05

Review 2.  Human cancer and cellular oncogenes.

Authors:  S Nishimura; T Sekiya
Journal:  Biochem J       Date:  1987-04-15       Impact factor: 3.857

3.  Cloning and Stable Expression of cDNA Coding For Platelet Endothelial Cell Adhesion Molecule -1 (PECAM-1, CD31) in NIH-3T3 Cell Line.

Authors:  Hamed Salehi-Lalemarzi; Dariush Shanehbandi; Farzaneh Shafaghat; Hajar Abbasi-Kenarsari; Behzad Baradaran; Ali Akbar Movassaghpour; Tohid Kazemi
Journal:  Adv Pharm Bull       Date:  2015-06-01
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.